share_log

BMO Capital Maintains Market Perform on Ingevity, Lowers Price Target to $43

BMO Capital Maintains Market Perform on Ingevity, Lowers Price Target to $43

BMO Capital维持Ingevity的市场表现,将目标股价下调至43美元
Benzinga ·  2023/11/09 14:32

BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Market Perform and lowers the price target from $54 to $43.

BMO Capital分析师约翰·麦克纳尔蒂维持Ingevity(纽约证券交易所代码:NGVT)的市场表现,并将目标股价从54美元下调至43美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发